Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2009 Oct;6(4):223-30.
doi: 10.1177/1479164109336041. Epub 2009 Aug 4.

Is glycaemia or insulin dose the stronger risk factor for coronary artery disease in type 1 diabetes?

Affiliations

Is glycaemia or insulin dose the stronger risk factor for coronary artery disease in type 1 diabetes?

Baqiyyah Conway et al. Diab Vasc Dis Res. 2009 Oct.

Abstract

Although coronary artery disease (CAD) is the leading cause of death in type 1 diabetes (T1D), the mechanisms responsible for the greatly increased risk are poorly understood. In particular, the role of glycaemic control is controversial with one study suggesting it predicts CAD mortality but not incidence. In this analysis, of the Pittsburgh Epidemiology of Diabetes Complications study cohort of T1D, we examine whether risk factors differ for CAD morbidity and mortality, with a specific focus on HbA1c and insulin dose. Participants (n=592) were followed for 18 years for incident non-fatal and fatal CAD. Cox stepwise regression was used to determine the independent risk factors for non-fatal and fatal CAD. Mean age and diabetes duration at study baseline were 29 and 20 years, respectively. There were 109 incident non-fatal and 48 fatal CAD events. Baseline HbA(1C) was an independent risk factor for fatal CAD, along with duration of diabetes and albuminuria. In contrast, baseline lower insulin dose was strongly predictive of non-fatal CAD, as was lower renal function, higher diastolic blood pressure, and lipids. HbA(1C) predicts CAD mortality while lower insulin dose and standard CAD risk factors predict CAD morbidity.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Nonfatal and fatal coronary artery disease by HbA1c and Insulin Dose

References

    1. Stout R. Insulin and atheroma. 20-yr perspective. Diabetes Care. 1990;13(6):631–54. - PubMed
    1. Kraemer F. Insulin deficiency alters cellular cholesterol metabolism in murine macrophages. Diabetes. 1986;35(7):764–770. - PubMed
    1. Krolewski A, Kosinski E, Warram J, Leland O, Busick E, Asmal A, Rand L, Christlieb A, Bradley R, Kahn C. Magnitude and determinants of coronary artery disease in juvenile-onset, insulin dependent diabetes mellitus. Am J Cardiol. 1987;59:750–755. - PubMed
    1. Nathan D, Cleary P, Backlund J, Genuth S, Lachin J, Orchard T, Raskin P, Zinman B, the Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications (DCCT/EDIC) Study Research Group Intensive diabetes treatment and cardiovascular disease in patients with type 1 diabetes. N Engl J Med. 2005;353:2643–2653. - PMC - PubMed
    1. Rossing P, Hougaard P, Borch-Johnsen K, Parving H. Predictors of mortality in insulin dependent diabetes: 10 year observational follow up study. BMJ. 1996;313(7060):779–84. - PMC - PubMed

Publication types

MeSH terms